We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+5.99%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$63.9B
AUM Growth
+$3.43B
(+5.7%)
Cap. Flow
+$105M
Cap. Flow
% of AUM
0.16%
Top 10 Holdings %
Top 10 Hldgs %
21.18%
Holding
4,866
New
886
Increased
1,406
Reduced
1,667
Closed
823
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3B |
| 2 |
Microsoft
MSFT
|
+$508M |
| 3 |
State Street Real Estate Select Sector SPDR ETF
XLRE
|
+$209M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$190M |
| 5 |
Qualcomm
QCOM
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$711M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$184M |
| 3 |
Oracle
ORCL
|
+$168M |
| 4 |
Gilead Sciences
GILD
|
+$140M |
| 5 |
Snowflake
SNOW
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.98% |
| 2 | Consumer Discretionary | 6.34% |
| 3 | Financials | 4.35% |
| 4 | Healthcare | 4.2% |
| 5 | Industrials | 3.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
POSCO
PKX
$16B
| $430K | ﹤0.01% |
+6,143
| New | +$402K |
|
|
CTRA
3202
PUT
DELISTED
Coterra Energy
CTRA
| $429K | ﹤0.01% |
+17,900
| New | +$442K |
|
|
MBX
3203
MBX Biosciences
MBX
$2.99B
| $428K | ﹤0.01% |
+16,470
| New | +$377K |
|
3204
Kratos Defense & Security Solutions
KTOS
$9.13B
| $428K | ﹤0.01% |
18,359
-10,686
| -37% | -$231K |
|
3205
Huron Consulting
HURN
$1.83B
| $426K | ﹤0.01% |
+3,919
| New | +$416K |
|
3206
Immersion
IMMR
$243M
| $426K | ﹤0.01% |
+47,742
| New | +$486K |
|
3207
Aquestive Therapeutics
AQST
$477M
| $425K | ﹤0.01% |
85,392
+51,991
| +156% | +$202K |
|
3208
Skyworks Solutions
SWKS
$9.3B
| $425K | ﹤0.01% |
4,300
-48
| -1% | -$5.09K |
|
3209
CALL
Robert Half
RHI
$3.87B
| $425K | ﹤0.01% |
6,300
-42,100
| -87% | -$2.67M |
|
3210
Pathward Financial
CASH
$1.84B
| $424K | ﹤0.01% |
6,430
-9,840
| -60% | -$633K |
|
3211
Revvity
RVTY
$12.3B
| $424K | ﹤0.01% |
3,321
-23
| -0.7% | -$2.71K |
|
|
ARR
3212
Armour Residential REIT
ARR
$2.03B
| $424K | ﹤0.01% |
20,780
+9,370
| +82% | +$191K |
|
3213
Zentalis Pharmaceuticals
ZNTL
$322M
| $424K | ﹤0.01% |
115,105
-33,650
| -23% | -$122K |
|
3214
Copa Holdings
CPA
$5.66B
| $422K | ﹤0.01% |
+4,500
| New | +$407K |
|
3215
Primis Financial Corp
FRST
$392M
| $422K | ﹤0.01% |
+34,630
| New | +$409K |
|
3216
PUT
VistaGen Therapeutics
VTGN
$9.38M
| $421K | ﹤0.01% |
+140,000
| New | +$478K |
|
3217
StoneX
SNEX
$8.86B
| $421K | ﹤0.01% |
17,341
-24,094
| -58% | -$568K |
|
3218
Zymeworks
ZYME
$1.74B
| $420K | ﹤0.01% |
33,438
-39,886
| -54% | -$434K |
|
3219
PUT
Innodata
INOD
$1.91B
| $419K | ﹤0.01% |
+25,000
| New | +$421K |
|
3220
Alliant Energy
LNT
$19.3B
| $419K | ﹤0.01% |
6,905
-43
| -0.6% | -$2.44K |
|
|
SRG
3221
CALL
Seritage Growth Properties
SRG
$135M
| $419K | ﹤0.01% |
90,000
| – | – |
|
3222
Titan Machinery
TITN
$474M
| $418K | ﹤0.01% |
30,019
-57,629
| -66% | -$864K |
|
3223
Axogen
AXGN
$2.17B
| $418K | ﹤0.01% |
29,815
-31,098
| -51% | -$344K |
|
3224
Celcuity
CELC
$4.14B
| $417K | ﹤0.01% |
+27,973
| New | +$461K |
|
3225
ClearPoint Neuro
CLPT
$441M
| $417K | ﹤0.01% |
37,201
-64,572
| -63% | -$618K |
|
Similar funds
Squarepoint's Q3 2024 Portfolio in Review
As of Q3 2024, Squarepoint held 4,866 positions worth $63.9B, up 5.7% from $60.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Squarepoint's Q3 2024 filing shows 886 new, 1,406 increased, 1,667 reduced and 823 closed positions. Its largest new stake was State Street Real Estate Select Sector SPDR ETF: 4,950,000 shares worth $221M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $711M.
By sector, the portfolio is most concentrated in Technology at 9% of assets, down from 9.1% a quarter earlier, followed by Consumer Discretionary and Financials.
- Squarepoint's largest Q3 2024 buy was State Street Real Estate Select Sector SPDR ETF: 4,950,000 shares worth $221M.
- Squarepoint added most to iShares Core S&P 500 ETF in Q3 2024, an estimated $3B increase.
- Squarepoint's biggest Q3 2024 reduction was Bristol-Myers Squibb, cutting an estimated $184M.
- Squarepoint fully exited State Street SPDR S&P 500 ETF Trust in Q3 2024, selling an estimated $711M.
- Squarepoint's ten largest holdings make up 21% of its $63.9B portfolio in Q3 2024.
- Squarepoint opened 886 new positions and closed 823 in Q3 2024.
- Squarepoint's portfolio value rose 5.7% quarter-over-quarter to $63.9B.
Based on Squarepoint's 13F filing for Q3 2024, filed 14 Nov 2024.